This study aims to investigate the value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery.
The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo a 68Ga-FAPI PET/CT when recurrence or metastasis is suspected. The imaging response measurements will be compared with follow-up results or histopathological findings as the gold standard.
Study Type
OBSERVATIONAL
Enrollment
40
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China
RECRUITINGDiagnosis of recurrent or metastatic thyroid cancer
The value of 68Ga-FAPI PET/CT in detecting recurrent and metastatic lesions in patients with thyroid cancer after surgery
Time frame: Within 1 week after enrollment
Standardized uptake value(SUV)
SUV of 68Ga-FAPI uptake on PET/CT images for tumor lesions
Time frame: Within 1 week after enrollment
Disease free survival
Disease free survival
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.